CAS: 1887014-12-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Olutasidenib REF: TM-T16384CAS: 1887014-12-1 | 99.59% | 75.00 €~976.00 € | Thu 09 May 24 | |
Olutasidenib REF: AN-AG01FTROCAS: 1887014-12-1 | 98% | 591.00 €~3,315.00 € | Thu 09 May 24 | |
Olutasidenib REF: 3D-MAD01412CAS: 1887014-12-1 | Min. 95% | To inquire | Thu 20 Jun 24 |
Olutasidenib
CAS:1887014-12-1
Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or …
Formula:
C18H15ClN4O2
Purity:
99.59%
Color and Shape:
Solid
Molecular weight:
354.79
Ref: TM-T16384
1mg | 75.00 € | |
5mg | 167.00 € | |
10mg | 259.00 € | |
25mg | 477.00 € | |
50mg | 694.00 € | |
100mg | 976.00 € | |
1ml*10 (DMSO) | 177.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: AN-AG01FTRO
5mg | 623.00 € | |
10mg | 591.00 € | |
25mg | 1,266.00 € | |
50mg | 2,101.00 € | |
100mg | 3,315.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Olutasidenib
CAS:1887014-12-1
Olutasidenib is a molecule that inhibits the platelet-derived growth factor receptor alpha (PDGFRα) and is …
Formula:
C18H15ClN4O2
Purity:
Min. 95%
Molecular weight:
354.79 g/mol
Ref: 3D-MAD01412
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024